Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, 94305, USA.
Department of Immuno-Oncology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, 91010, USA.
Nat Commun. 2018 Aug 10;9(1):3194. doi: 10.1038/s41467-018-05211-7.
Macrophage-mediated programmed cell removal (PrCR) is a process essential for the clearance of unwanted (damaged, dysfunctional, aged, or harmful) cells. The detection and recognition of appropriate target cells by macrophages is a critical step for successful PrCR, but its molecular mechanisms have not been delineated. Here using the models of tissue turnover, cancer immunosurveillance, and hematopoietic stem cells, we show that unwanted cells such as aging neutrophils and living cancer cells are susceptible to "labeling" by secreted calreticulin (CRT) from macrophages, enabling their clearance through PrCR. Importantly, we identified asialoglycans on the target cells to which CRT binds to regulate PrCR, and the availability of such CRT-binding sites on cancer cells correlated with the prognosis of patients in various malignancies. Our study reveals a general mechanism of target cell recognition by macrophages, which is the key for the removal of unwanted cells by PrCR in physiological and pathophysiological processes.
巨噬细胞介导的程序性细胞清除(PrCR)是清除不需要的(受损、功能失调、衰老或有害)细胞的必要过程。巨噬细胞对适当靶细胞的检测和识别是成功进行 PrCR 的关键步骤,但分子机制尚不清楚。在这里,我们使用组织更新、癌症免疫监视和造血干细胞模型,表明诸如衰老的中性粒细胞和存活的癌细胞等不需要的细胞容易被巨噬细胞分泌的钙网蛋白(CRT)“标记”,从而通过 PrCR 清除它们。重要的是,我们确定了 CRT 结合的靶细胞上的唾液酸聚糖,以调节 PrCR,并且癌细胞上 CRT 结合位点的可用性与各种恶性肿瘤患者的预后相关。我们的研究揭示了巨噬细胞识别靶细胞的一般机制,这是 PrCR 在生理和病理生理过程中清除不需要的细胞的关键。